Genes News and Research

RSS

Allergy - it's in the genes

In a world first scientists at theWestmead Millennium Institute have identified how a gene associated with allergic diseases such as asthma and eczema works, providing new hope for potential drug treatments.

28 May 2008

febit receives U.S. patent for microfluidic extraction method

febit today announced the receipt of US patent #7320862 on its microfluidic microarray-based method for extraction of DNA and RNA.

27 May 2008

Avoiding spleen removal for Cooley's anemia sufferers

Researchers from Weill Cornell Medical College may have discovered the precise role of a gene in one of the world's most common blood disorders, beta-thalassemia, commonly known as Cooley's anemia. Along with sickle-cell anemia, Cooley's anemia is the most commonly inherited disease in the world, affecting many people of Mediterranean descent, and 20 out of every 100,000 African-Americans. The World Health Organization estimates that between 50,000-100,000 children are born with the disease each year.

27 May 2008

RNA toxicity contributes to neurodegenerative disease

Expanding on prior research performed at the University of Pennsylvania, Penn biologists have determined that faulty RNA, the blueprint that creates mutated, toxic proteins, contributes to a family of neurodegenerative disorders in humans.

27 May 2008

New cheaper method for mapping disease genes

Scientists at the Swedish medical university Karolinska Institutet have developed a new DNA-sequencing method that is much cheaper than those currently in use in laboratories. They hope that this new method will make it possible to map disease genes in large patient groups, which in turn can mean quicker breakthroughs for new treatments for a wide variety of diseases.

26 May 2008

New treatments for viral and other diseases by blocking genes

The elusive goal of developing effective treatments for viral diseases such as AIDS and influenza has been brought closer by dramatic progress in the ability to interfere with viral genetic machinery. The stage was set for a coordinated European effort to accelerate research and stimulate development of new treatments against viral diseases at a recent research conference organised by the European Science Foundation (ESF).

26 May 2008

Researchers find multiple cancer genes cooperate to cause malignant cell transformation

Pinpointing new targets for cancer treatments is as difficult as finding a needle in a haystack, yet a University of Rochester team has discovered an entire novel class of genes they believe will lead to a greater understanding of cancer cell function and the next generation of effective and less harmful therapies for patients.

26 May 2008

Common gene disorder doubles risk of lung cancer, even among nonsmokers

Mayo Clinic researchers have found that carrying a common genetic disorder doubles the risk of developing lung cancer in smokers and nonsmokers.

26 May 2008

Why do some heavy drinkers develop mouth and throat cancers while others do not?

A study by researchers in Europe has revealed why some heavy drinkers develop mouth and throat cancers while others do not and also why some people get drunk quickly.

26 May 2008

Scientists back the use of maize as an efficient 'factory' for protein-based pharmaceutical products

Scientists from the Universidad de Lleida (University of Lleida) have published a study confirming that maize seeds are an effective and sure platform within molecular agriculture to alleviate diseases. Over the next few years AIDS could be one of the first diseases to benefit from these results, although regulations for this technology are being developed at the same time as research is being undertaken.

25 May 2008

Embryonic pathway delivers stem cell traits

Studies of how cancer cells spread have led to a surprising discovery about the creation of cells with adult stem cell characteristics, offering potentially major implications for regenerative medicine and for cancer treatment.

25 May 2008

How cells size up their growth opportunities

The intricate mechanisms that switch cell growth on and off are regulated by mammalian target of rapamycin (mTOR) protein complexes, which sense nutrients within the cell. When amino-acids are abundant, the protein complexes promote cellular growth, and when nutrients are scarce they signal that hard times are ahead to the cell. But just how nutrients regulate mTOR signaling to control size has remained a mystery. Now, scientists in the lab of Whitehead Member David Sabatini have found the first step in the process.

25 May 2008

Experimental drug blocks prostate cancer in animal study

An experimental drug has blocked the progression of prostate cancer in an animal model with an aggressive form of the disease, new research shows.

22 May 2008

Fluorescent 'barcodes' called nanostrings could revolutionise diagnostics

A new technology with research and clinical application including the early detection of disease has been invented and developed by University of Queensland researchers.

From NanoString Technologies 22 May 2008

Research shows protecting p53 from degradation also defends metastasis-promoter

Efforts to protect the tumor-suppressor p53 could just as easily shelter a mutant version of the protein, causing cancer cells to thrive and spread rather than die, according to research by scientists at The University of Texas M. D. Anderson Cancer Center reported in the current issue of the journal Genes and Development.

22 May 2008

Yerkes researchers develop first transgenic nonhuman primate model of Huntington's disease

In the first study of its kind, researchers at the Yerkes National Primate Research Center, Emory University, in collaboration with researchers from the Department of Human Genetics at Emory's School of Medicine, have developed the first transgenic nonhuman primate model of Huntington's disease (HD), one of the most devastating human neurodegenerative diseases.

22 May 2008

NCI scientists visualize gene regulation in living cells

A research team led by scientists at the National Cancer Institute (NCI), part of the National Institutes of Health (NIH), has applied advanced imaging methods and computer simulations to be able to glance at the regulation of a cancer-related gene in a living cell. They found that the efficiency with which the components of the cell's gene reading machinery come together has an impact on gene expression, the process by which a gene translates its information into a new protein. The findings, published in the May 23, 2008 issue of Molecular Cell, shed new light on the means by which living cells regulate gene activity.

22 May 2008

RNA toxicity contributes to neurodegenerative disease

21 May 2008

Scientists reveal the genetic determinants of fat storage in cells

New research by the Gladstone Institutes of Cardiovascular Disease (GICD) and the University of California, San Francisco (UCSF), has revealed the genetic determinants of fat storage in cells, which may lead to a new understanding of and potential treatments for obesity, diabetes, and heart disease. While scientists have long understood that lipid droplets contribute to fat build up in cells, the genes involved in droplet biology have been a focus of extensive research.

21 May 2008

New biological classification of ovarian cancer

A thesis from The Sahlgrenska Academy in Sweden shows that it might be possible to predict with great probability which women with ovarian cancer will survive the disease before painful treatment with antineoplastic agents. A better prognosis would considerably improve the quality of life of patients since the treatment could be made more effective and thereby result in fewer side effects.

21 May 2008